Molina Healthcare, Inc. (NYSE:MOH) Shares Acquired by Capital International Investors

Capital International Investors lifted its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH) by 0.9% during the 1st quarter, HoldingsChannel.com reports. The fund owned 1,665,801 shares of the company’s stock after buying an additional 15,264 shares during the period. Capital International Investors’ holdings in Molina Healthcare were worth $684,361,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Capital Group Private Client Services Inc. lifted its holdings in shares of Molina Healthcare by 61.3% during the 1st quarter. Capital Group Private Client Services Inc. now owns 8,886 shares of the company’s stock valued at $3,651,000 after acquiring an additional 3,377 shares in the last quarter. Forte Capital LLC ADV increased its stake in Molina Healthcare by 2.8% during the 1st quarter. Forte Capital LLC ADV now owns 14,523 shares of the company’s stock worth $5,966,000 after buying an additional 390 shares during the period. Shell Asset Management Co. increased its stake in Molina Healthcare by 124.1% during the 1st quarter. Shell Asset Management Co. now owns 2,369 shares of the company’s stock worth $973,000 after buying an additional 1,312 shares during the period. Pitcairn Co. increased its stake in Molina Healthcare by 111.3% during the 1st quarter. Pitcairn Co. now owns 1,828 shares of the company’s stock worth $751,000 after buying an additional 963 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Molina Healthcare during the 1st quarter worth $206,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

Wall Street Analyst Weigh In

MOH has been the topic of several analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $406.00 price target on shares of Molina Healthcare in a research note on Tuesday. Baird R W raised shares of Molina Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Barclays dropped their price target on shares of Molina Healthcare from $437.00 to $430.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 25th. Wells Fargo & Company dropped their price target on shares of Molina Healthcare from $375.00 to $315.00 and set an “equal weight” rating on the stock in a research note on Monday. Finally, TD Cowen dropped their target price on shares of Molina Healthcare from $412.00 to $351.00 and set a “buy” rating for the company in a research report on Wednesday. One research analyst has rated the stock with a sell rating, five have issued a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Molina Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $376.18.

Insider Activity at Molina Healthcare

In related news, Director Ronna Romney sold 250 shares of the business’s stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total transaction of $85,817.50. Following the completion of the sale, the director now owns 16,945 shares of the company’s stock, valued at approximately $5,816,710.15. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Molina Healthcare news, COO James Woys sold 10,000 shares of the business’s stock in a transaction dated Wednesday, May 22nd. The shares were sold at an average price of $345.15, for a total transaction of $3,451,500.00. Following the completion of the transaction, the chief operating officer now directly owns 53,613 shares of the company’s stock, valued at approximately $18,504,526.95. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Ronna Romney sold 250 shares of the business’s stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total transaction of $85,817.50. Following the transaction, the director now directly owns 16,945 shares of the company’s stock, valued at $5,816,710.15. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

Molina Healthcare Stock Performance

Shares of NYSE:MOH traded up $11.19 during trading on Friday, reaching $335.36. 1,251,082 shares of the company’s stock traded hands, compared to its average volume of 484,697. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.49 and a quick ratio of 1.49. Molina Healthcare, Inc. has a 12 month low of $282.96 and a 12 month high of $423.92. The company has a 50 day moving average of $307.20 and a 200-day moving average of $353.65. The stock has a market capitalization of $19.65 billion, a P/E ratio of 18.20, a price-to-earnings-growth ratio of 0.89 and a beta of 0.58.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, July 24th. The company reported $5.86 earnings per share for the quarter, beating analysts’ consensus estimates of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 29.17%. The business had revenue of $9.88 billion during the quarter, compared to the consensus estimate of $9.75 billion. During the same quarter in the prior year, the firm earned $5.65 EPS. The company’s revenue for the quarter was up 18.7% compared to the same quarter last year. On average, equities analysts expect that Molina Healthcare, Inc. will post 23.56 EPS for the current year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.